Your browser doesn't support javascript.
loading
Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.
Shi, Qing; Zhu, Yasheng; Ma, Jian; Chang, Kun; Ding, Dongling; Bai, Yang; Gao, Kun; Zhang, Pingzhao; Mo, Ren; Feng, Kai; Zhao, Xiaying; Zhang, Liang; Sun, Huiru; Jiao, Dongyue; Chen, Yingji; Sun, Yinghao; Zhao, Shi-Min; Huang, Haojie; Li, Yao; Ren, Shancheng; Wang, Chenji.
Afiliación
  • Shi Q; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Zhu Y; Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, People's Republic of China.
  • Ma J; Department of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, People's Republic of China.
  • Chang K; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.
  • Ding D; Department of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, People's Republic of China.
  • Bai Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.
  • Gao K; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA.
  • Zhang P; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA.
  • Mo R; Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 200090, People's Republic of China.
  • Feng K; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.
  • Zhao X; Department of Urology, Inner Mongolia Urological Institute, Inner Mongolia Autonomous Region People's Hospital, Hohhot, 010017, Inner Mongolia, People's Republic of China.
  • Zhang L; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Sun H; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Jiao D; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Chen Y; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Sun Y; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Zhao SM; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Huang H; Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, People's Republic of China.
  • Li Y; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
  • Ren S; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA.
  • Wang C; Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
Mol Cancer ; 18(1): 170, 2019 11 26.
Article en En | MEDLINE | ID: mdl-31771591
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas Represoras / Proteínas Nucleares / Proteínas de Ciclo Celular / Resistencia a Antineoplásicos / Docetaxel / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas Represoras / Proteínas Nucleares / Proteínas de Ciclo Celular / Resistencia a Antineoplásicos / Docetaxel / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article